Recursion Pharmaceuticals (RXRX) Gross Margin (QoQ) (2021 - 2026)

Recursion Pharmaceuticals (RXRX) Gross Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Recursion Pharmaceuticals 1.69 Bn 1.14 Bn -3.82 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 4,317.00
Mar 31, 2026 -15,282.00
Dec 31, 2025 24,364.00
Sep 30, 2025 -17,893.00
Jun 30, 2025 4,316.00
Mar 31, 2025 13,339.00
Dec 31, 2024 -23,512.00
Sep 30, 2024 1,749.00
Jun 30, 2024 1,714.00
Mar 31, 2024 978.00
Dec 31, 2023 1,254.00
Sep 30, 2023 -1,811.00
Jun 30, 2023 1,743.00
Mar 31, 2023 -2,332.00
Dec 31, 2022 3,783.00
Sep 30, 2022 6,830.00
Jun 30, 2022 -3,915.00
Mar 31, 2022 -14,624.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00